Resistance to pancuronium caused by theophylline and forskolin
García, E.; Gómez, E.; Calvo, R.; Rodríguez Sasiain, J.M.; Martínez Jordá, R.; Aguilera, L.
Revista Espanola de Anestesiologia y Reanimacion 35(4): 191-193
1988
ISSN/ISBN: 0034-9356 PMID: 3175192 Document Number: 325385
Document emailed within 1 workday
Related Documents
Tuganowski, W.; Korczyńska, I.; Wasik, K.; Wójcik, B.; Bukowski, M. 1989: Effects of forskolin on the longitudinal internal resistance (ri) in rabbit sinus node strips Acta Physiologica Polonica 40(2): 164-170Yamashita, M.; Shiga, T.; Matsuki, A.; Minagawa, H.; Oyama, T. 1983: Marked resistance to pancuronium in severely burned patients Masui. Japanese Journal of Anesthesiology 32(2): 253-255
Torresi, S.; Pasotti, E.M. 1984: A case of prolonged curarization caused by the interaction of pancuronium and streptomycin Minerva Anestesiologica 50(4): 143-145
Wahl, M.; Kuschinsky, W. 1975: Effects of adenosine and theophylline upon cerebral resistance to flow Arzneimittel-Forschung 25(10): 1678-1679
Wang, F. 2006: To enhance the research of antibiotic resistance and infection caused by drug-resistance bacteria Zhonghua Yi Xue Za Zhi 86(9): 579-580
Stefanková, Z.; Barancík, M.; Breier, A. 1996: Overcoming of P-glycoprotein mediated vincristine resistance of L1210/VCR mouse leukemic cells could be induced by pentoxifyline but not by theophylline and caffeine Neoplasma 43(1): 11-15
Mano, K. 1996: The development of slow-release theophylline products and revaluation of theophylline's role as a bronchodilator Nihon Rinsho. Japanese Journal of Clinical Medicine 54(11): 3093-3101
Wemhöner, S.; Oellerich, M.; Sybrecht, G. 1981: Theophylline therapy in obstructive respiratory diseases. 1. Bioavailability and pharmacokinetics of various theophylline preparations Praxis und Klinik der Pneumologie 35(1): 36-41
Zimmermann, I.; Schulz, H.U.; Ulmer, W.T. 1978: Blood level courses after i.v., i.m. and p.o. administration of theophylline ethylendiamine and pH-neutral solution of theophylline Arzneimittel-Forschung 28(9): 1652-1654
Laaban, J.P.; Dupeyron, J.P.; Guyon, F.; Drieu, L.; Rochemaure, J.; Fabiani, P. 1986: Intravenous theophylline: adaptation of dosage to blood theophylline levels at admission and to clearance Annales de Medecine Interne 137(5): 415-419
Moore, L.D.; Taylor, A.T. 1988: Theophylline dosing and theophylline level testing in a family practice population Journal of Family Practice 27(1): 57-61
Rachelefsky, G.S.; Katz, R.M.; Siegel, S.C. 1978: A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels Annals of Allergy 40(4): 252-257
Jiang, C.S.; Kilfeather, S.A.; Pearson, R.M.; Turner, P. 1984: The stimulatory effects of caffeine, theophylline, lysine-theophylline and 3-isobutyl-1-methylxanthine on human sperm motility British Journal of Clinical Pharmacology 18(2): 258-262
Serajuddin, A.T. 1986: Comparative thermal properties of the monohydrates of sodium theophylline and theophylline Journal of Pharmacy and Pharmacology 38(2): 93-96
Dayer, P.; Deom, A.; Roth, M. 1982: Absorption of theophylline: pharmacokinetics of 2 water-alcohol solutions of theophylline Pharmaceutica Acta Helvetiae 57(1): 27-32
Harder, S.; Staib, A.H.; Stauder, J. 1986: Individual theophylline doses following ambulatory determination of theophylline clearance Praxis und Klinik der Pneumologie 40(8): 334-338
Tarasova, O.N.; Ziganshin, A.S.; Danilova, N.P.; Vasilov, R.G.; Kaganov, S.I. 1991: An immunoenzyme method of controlling the concentration of theophylline in the blood of children with bronchial asthma during treatment with theophylline preparations Laboratornoe Delo 4: 18-21
Schmidt, G.; Ranke, C.; Creutzig, H.; Oellerich, M.; Sybrecht, G.W. 1983: Optimizing of therapy with theophylline preparations in obstructive respiratory diseases. 4. Effect of theophylline on mucociliary clearance and maximal inspiratory mouth occlusion pressure Praxis und Klinik der Pneumologie 37(4): 154-160
Moro, M.L.; Pantosti, A.; Boccia, D. 2002: Antibiotic microbial resistance surveillance in invasive infections caused by Streptococcus pneumoniae and Staphylococcus aureus: the EARSS (European Antimicrobial Resistance Surveillance System) project in Italy (April 1999-April 2000) Annali di igiene: medicina preventiva e di comunita 14(5): 361-371
Mégraud, F. 1997: Problems caused by antibiotic resistance of Helicobacter pylori Presse Medicale 26(37): 1775-1780